Discussion

The CDC 2016 came up with the following strategies, regarding the use of opioid use disorder to prevent CNS complications (Jean, 2016). Among the strategies which were discussed in CNS include the following. Paediatricians should address the exclusive sensitivities of prescribing opioid medications to expectant women, and non-expectant women, who are still in their reproductive ages. The recommendations therefore include discussing the effects of prolonged use of opioid, since it may affect the conception periods, and future pregnancies, and how women who suffer from opioid disorder can also avoid unwanted pregnancy (Nora, 2016). Similarly, other recommendations were providing nonopioid pharmacological therapy for the management of chronic pain, and also recommending the lowest effective dosage when commencing opioids. In addition, from March 2016, it is required by the Food and Drug Administration, continued and immediate-release opioid drugs to include a warning on the box, which notifies the patients about the effects of prolonged use of opioid during pregnancy, as it may lead to central nervous system (CNS) complications.

It is significant to provide requirements of treatment for expectant women who might be suffering from opioid use disorder (Nora, 2016). Therapeutically supervised interfering of opioids in expectant women is consequently related with high deterioration rates as related to methadone upkeep. The administration for substance and mental health service has been reviewed to improve the capacity to provide MAT for expectant women with Opioid use disorder. It is consequently significant for medical providers to evaluate simultaneous substance abuse and depression and transmittable comorbidities of opioid use disorder (Jean, 2016). Furthermore, medical providers need expect that children born of mothers receiving MAT might be affected by CNS. It is therefore necessary for an association with paediatricians to assess babies’ utero opioid exposure for any symptoms or signs of CNS.

Reference

Jean Y. Ko, Sara W, Wanda D. B, Stephen W. P, Cheryl S. B, Kimberly A. Y, Rebecca N, John I. (2017). CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome: Centres for Disease Control and Prevention. Retrieved from: https://www.cdc.gov/mmwr/volumes/66/wr/mm6609a2.htm

Nora, D. V. (2016). What Science tells us About Opioid Abuse and Addiction: National Institute on Drug Abuse: Advancing Addiction Science.